Impact of age on the false negative rate of human papillomavirus DNA test in patients with atypical squamous cells of undetermined significance
- PMID: 25798425
- PMCID: PMC4366864
- DOI: 10.5468/ogs.2015.58.2.117
Impact of age on the false negative rate of human papillomavirus DNA test in patients with atypical squamous cells of undetermined significance
Abstract
Objective: Human papillomavirus (HPV) test was incorporated into the triage of lesser abnormal cervical cytologies: atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL). This study aimed to evaluate the impact of age on the efficacy of HPV testing in patients with lesser abnormal cervical cytologies.
Methods: A total of 439 patients with ASCUS or LSIL were included. The association between age groups and the diagnostic performances of HPV test for high-grade cervical intraepithelial neoplasia (CIN2+) was evaluated.
Results: Median age was 44 years (range, 17 to 75 years). ASCUS was more frequently observed in older patients while LSIL was more common in younger patients (P=0.002). CIN2+ was found in 11.3% (32/284) of the ASCUS patients and 12.9% (20/155) of patients with LSIL. Older patients with ASCUS showed lower HPV infection rates (P=0.025), but not LSIL (P=0.114). However, the prevalence of CIN2+ was similar between the age groups with ASCUS or LSIL. In patients with ASCUS, the false negative rate of HPV test for CIN2+ was 6.2%. The false negative rate of the HPV test became higher with increasing of the age after the age of 50 (P=0.034).
Conclusion: Our findings suggest that false negative rate of the HPV test for CIN2+ in ASCUS patients older than 50 years might become higher with increasing of the age. Negative HPV results in patients of the age >50 years with ASCUS should be carefully interpreted.
Keywords: Age; Atypical squamous cells of the cervix; Human papillomavirus DNA tests; Uterine cervical dysplasia.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Similar articles
-
Management of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesions of the uterine cervix with human papilloma virus infection among young women aged less than 25 years.Diagn Cytopathol. 2016 Dec;44(12):959-963. doi: 10.1002/dc.23533. Epub 2016 Oct 7. Diagn Cytopathol. 2016. PMID: 27714942
-
The utility of high-risk HPV testing in the management of women 30 to 64 years of age with low-grade squamous intraepithelial lesions on cervical cytology.J Am Soc Cytopathol. 2015 Sep-Oct;4(5):290-293. doi: 10.1016/j.jasc.2015.02.006. Epub 2015 Feb 23. J Am Soc Cytopathol. 2015. PMID: 31051767
-
Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group.J Natl Cancer Inst. 2000 Mar 1;92(5):397-402. doi: 10.1093/jnci/92.5.397. J Natl Cancer Inst. 2000. PMID: 10700419 Clinical Trial.
-
The clinical application of HPV E6/E7 mRNA testing in triaging women with atypical squamous cells of undetermined significance or low-grade squamous intra-epithelial lesion Pap smear: A meta-analysis.J Cancer Res Ther. 2017;13(4):613-620. doi: 10.4103/jcrt.JCRT_56_17. J Cancer Res Ther. 2017. PMID: 28901302 Review.
-
HPV DNA testing in the triage of atypical squamous cells of undetermined significance (ASCUS): cost comparison of two methods.Diagn Cytopathol. 2005 Aug;33(2):138-43. doi: 10.1002/dc.20316. Diagn Cytopathol. 2005. PMID: 16007672
Cited by
-
Clinicopathologic significance and treatment of ASC-US in cervical cytology.Int J Clin Exp Pathol. 2020 Feb 1;13(2):307-316. eCollection 2020. Int J Clin Exp Pathol. 2020. PMID: 32211114 Free PMC article.
-
Quality Assurance in Cervical Cancer Screening: Evaluation of Sample Adequacy in HPV DNA Testing.J Med Virol. 2025 Jul;97(7):e70482. doi: 10.1002/jmv.70482. J Med Virol. 2025. PMID: 40600419 Free PMC article.
-
Factors, associated with elevated concentration of soluble carbonic anhydrase IX in plasma of women with cervical dysplasia.Sci Rep. 2022 Sep 13;12(1):15397. doi: 10.1038/s41598-022-19492-y. Sci Rep. 2022. PMID: 36100684 Free PMC article.
-
Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study).BMJ Open. 2016 Apr 25;6(4):e010660. doi: 10.1136/bmjopen-2015-010660. BMJ Open. 2016. PMID: 27113237 Free PMC article.
-
Retrospective analysis of cervical cancer and precancerous lesions in patients with atypical squamous cells of undetermined significance in China.Medicine (Baltimore). 2019 Dec;98(49):e18239. doi: 10.1097/MD.0000000000018239. Medicine (Baltimore). 2019. PMID: 31804350 Free PMC article.
References
-
- Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol. 1998;92:727–735. - PubMed
-
- Kulasingam SL, Kim JJ, Lawrence WF, Mandelblatt JS, Myers ER, Schiffman M, et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS) J Natl Cancer Inst. 2006;98:92–100. - PubMed
-
- Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA. 2002;287:2382–2390. - PubMed
-
- Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al. 2012 Updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013;17:S1–S27. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources